Current problems and future directions of transfusion-induced alloimmunization: summary of an NHLBI working group.
In April 2010, a working group sponsored by the National Heart, Lung, and Blood Institute was assembled to identify research strategies to improve our understanding of alloimmunization caused by the transfusion of allogeneic blood components and to evaluate potential approaches to both reduce its occurrence and manage its effects. Significant sequelae of alloimmunization were discussed and identified, including difficulties in maintaining chronic transfusion of red blood cells and platelets, hemolytic disease of the newborn, neonatal alloimmune thrombocytopenia, and rejection of transplanted cells and tissues. The discussions resulted in a consensus that identified key areas of future research and developmental areas, including genetic and epigenetic recipient factors that regulate alloimmunization, biochemical specifics of transfused products that affect alloimmunization, and novel technologies for high-throughput genotyping to facilitate extensive and efficient antigen matching between donor and recipient. Additional areas of importance included analysis of unappreciated medical sequelae of alloimmunization, such as cellular immunity and its effect upon transplant and autoimmunity. In addition, support for research infrastructure was discussed, with an emphasis on encouraging collaboration and synergy of animal models biology and human clinical research. Finally, training future investigators was identified as an area of importance. In aggregate, this communication provides a synopsis of the opinions of the working group on the above issues and presents both a list of suggested priorities and the rationale for the topics of focus. The areas of research identified in this report represent potential fertile ground for the medical advancement of preventing and managing alloimmunization in its different forms and mitigating the clinical problems it presents to multiple patient populations.
Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Children's Healthcare of Atlanta, Division of Pediatric Hematology/Oncology, Emory University School of Medicine, Atlanta, Georgia, USA. jzimrin@emory.edu
James C
JC
Zimring
Lis
L
Welniak
John W
JW
Semple
Paul M
PM
Ness
Sherrill J
SJ
Slichter
Steven L
SL
Spitalnik
D000328:Adult; D000818:Animals; D016824:Antigens, Human Platelet / Q000276:immunology; D001789:Blood Group Antigens / Q000276:immunology; D001787:Blood Group Incompatibility / Q000276:immunology / Q000517:prevention & control; D003299:Cooperative Behavior; D005260:Female; D005544:Forecasting; D006292:Health Priorities; D006801:Humans; D007231:Infant, Newborn; D007518:Isoantibodies / Q000032:analysis / Q000096:biosynthesis; D016131:Lymphocyte Subsets / Q000276:immunology; D008297:Male; D023421:Models, Animal; D054555:National Heart, Lung, and Blood Institute (U.S.); D011247:Pregnancy; D012108:Research Personnel / Q000193:education / Q000600:supply & distribution; D054098:Thrombocytopenia, Neonatal Alloimmune / Q000276:immunology / Q000517:prevention & control; D065227:Transfusion Reaction; D014181:Transplantation Immunology; D014481:United States
D016824:Antigens, Human Platelet; D001789:Blood Group Antigens; D007518:Isoantibodies
Vox Sang. 2010 Aug 1;99(2):99-111
20345515
Transfus Med Rev. 2008 Oct;22(4):255-67
18848153
Br J Haematol. 1995 Dec;91(4):1000-5
8547111
Arch Pathol Lab Med. 1995 Jan;119(1):42-5
7802552
Blood. 2008 Sep 15;112(6):2546-53
18535200
N Engl J Med. 1997 Dec 25;337(26):1861-9
9417523
Transfusion. 2009 Mar;49(3):505-12
19040411
Blood. 2009 Nov 5;114(19):4279-82
19713462
Blood. 2010 Feb 11;115(6):1247-53
20007808
Transfusion. 1997 Apr;37(4):357-61
9111271
J Clin Invest. 2009 Sep;119(9):2787-94
19726874
Transfusion. 2009 Sep;49(9):1825-35
19453983
Early Hum Dev. 2008 Aug;84(8):515-23
18621490
Transfusion. 1994 Jul;34(7):558-60
8053035
Transfusion. 2001 Jun;41(6):766-70
11399817
Blood. 2009 Sep 10;114(11):2315-22
19525479
Transfusion. 2008 Nov;48(11):2461-75
19054376